Capricorn Partners

Capricorn Partners, established in 1993, is a Belgium-based asset management firm specializing in venture capital. It invests in innovative European companies that leverage technology for a competitive edge, focusing on sectors such as information technology, healthcare, and clean technology. The firm's investment team comprises experienced professionals with deep technology expertise and broad industrial experience.

Jan Avonts

Investment Director

Damien van der Bijl

Investment Director

Damien van der Bijl

Investment Director

Frank Bulens

Partner

Daniela Arruda Costa

Investment Associate

Olaf Corper

Investment Manager Quoted Equity and Partner

Antoine D’Hollander

Investment Director

Katrin Geyskens

Partner

Ludwig Goris

Investment Manager

Steven Lambert

Investment Partner Digital

Steven Lambert

Investment Partner Digital

Marc Lambrechts Ph.D

Investment Director

Steven Levecke

Partner

Jos B. Peeters

Founder and Managing Partner

Filip Pintelon

Investment Partner Health

Wouter Van de Putte

Investment Director

Johan Reynaert

Investment Manager

Ekaterina Smirnyagina

Partner

Claude Stoufs

Partner and Senior Investment Manager

Sabine Vermassen

Partner, Member of the Executive Committee and Board Member

Simon Wouters

Investment Analyst

103 past transactions

Gradyent

Series B in 2025
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, that specializes in optimizing heating systems for district heating companies. Founded in 2019, Gradyent leverages Digital Twin technology, which involves creating a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows for real-time optimization of heating systems and facilitates simulations of future scenarios. As a result, clients can achieve significant reductions in heat loss, CO2 emissions, and fuel costs—averaging 20%, 10%, and 5-10%, respectively. Gradyent's platform not only enhances the efficiency of heating networks but also provides dynamic forecasting, real-time status updates, and automatic detection of network changes, allowing clients to securely access vital information from any location at any time.

InsectSense

Pre Seed Round in 2025
Complex sensing startup inspired by insects and their sensitive sensors that have evolved over millions of years for “detection” and “measurement” of compounds in low concentrations.

Minze Health

Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

Econic Technologies

Venture Round in 2024
Econic Technologies Ltd. is a UK-based chemical technology company that specializes in developing innovative processes for producing polymers and polyurethanes using carbon dioxide and epoxides. Founded in 2011 and located in Macclesfield, the company focuses on transforming waste CO2 into valuable materials through advanced catalyst chemistry. Its product offerings include polycarbonates and polycarbonate polyols, which find applications in various sectors such as mattresses, home insulation, footwear, packaging, and construction. The company’s technology not only reduces dependence on fossil fuels but also aims to provide environmental benefits by mitigating greenhouse gas emissions. With a team of skilled scientists and engineers operating from a state-of-the-art facility at Alderley Park, Econic Technologies is committed to advancing sustainable practices in the plastics industry while fostering economic growth.

Thryve

Series A in 2024
Thryve is a developer of an application programming interface (API) platform that facilitates access to health data from various wearable and medical devices. By integrating with popular data sources such as Apple Health, Google Fit, Huawei Health, and Samsung Health, Thryve enables users to consolidate their health sensor data from devices like smartwatches and blood glucose meters. This unified approach provides insurers, researchers, and developers with real-time harmonized health information, allowing for improved services and individualized health interventions. Through its technology, Thryve aims to streamline the accessibility and usability of fragmented health data, enhancing the overall experience for users and stakeholders in the healthcare sector.

NEFFA

Seed Round in 2024
NEFFA is a company focused on revolutionizing the fashion industry by addressing its environmental impact through innovative production methods. The fashion sector is known for its significant contribution to global CO2 emissions and water contamination. NEFFA employs a sustainable approach by utilizing a digital design interface that allows for 3D design and the application of parametric textures. Their production method creates affordable, recyclable 3D molds without the need for high heat or pressure, enabling efficient manufacturing. Currently, NEFFA specializes in using mycelium to produce MycoTEX, a sustainable textile, but their technology can also accommodate various biomaterials grown through liquid fermentation, such as algae and collagen. This seamless production process emphasizes custom-fit products and on-demand manufacturing, reducing waste and promoting eco-friendly clothing solutions.

Chainels

Series A in 2023
Chainels is a comprehensive tenant experience platform designed for multi-tenant environments such as shopping centers, mixed-use developments, offices, and residential complexes. Based in Rotterdam, the company aims to enhance communication and tenant retention by providing an intuitive app that facilitates the management of operations, amenities, and data reporting. The platform enables stakeholders to streamline property management processes and deliver high-quality services to tenants. Chainels serves over 400 communities, encompassing around 50,000 companies and households across multiple countries. Its client base includes notable organizations like Multi Corporation, Amvest/Fuzer, and CBRE, highlighting its impact on improving tenant experiences and operational efficiency in various property types.

Fruitcore Robotics

Series B in 2022
Fruitcore Robotics specializes in the design and development of robotic systems aimed at automating industrial processes. By integrating intelligent software with advanced mechatronics, the company offers optimized robotic solutions for various applications, including workpiece handling, fitting, assembling, screwing, palletizing, stacking, packaging, and workpiece testing. These systems enable manufacturers to enhance operational efficiency while reducing time and costs associated with production tasks.

Trillium Renewable Chemicals

Series A in 2022
Trillium Renewable Chemicals, founded in 2021 and based in Knoxville, Tennessee, specializes in the manufacture of chemicals derived from renewable feedstocks. The company focuses on producing acrylic molecules and glycols, providing a sustainable alternative to fossil-based acrylonitrile through the use of glycerol. By offering clients a secure supply of renewable chemicals, Trillium aims to reduce carbon emissions and improve safety while ensuring competitive pricing. Their commitment to sustainability positions them as a key player in the industrial chemicals market.

Minze Health

Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract problems, particularly focusing on urologic, pelvic health, and continence care. Its platform facilitates the diagnostic and treatment processes, as well as remote patient monitoring for individuals suffering from lower urinary tract symptoms (LUTS). Minze Health's innovative solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers around the globe, enabling healthcare professionals to effectively diagnose and monitor their patients both in clinical settings and private practices.

neotiv

Seed Round in 2022
Neotiv GmbH, founded in 2017 and headquartered in Magdeburg, Germany, specializes in mobile software solutions aimed at monitoring memory function and supporting individuals with dementia. The company offers memory tests designed to assess brain regions affected by aging and early Alzheimer's disease. Its health monitoring application not only tracks users' memory performance over time but also provides insights derived from scientific research, making them accessible to a wider audience. By combining neurodegenerative disease research with its digital platform, Neotiv enables healthcare professionals and researchers to enhance early detection and management of memory-related issues.

Xanadu

Series C in 2022
Xanadu is a company founded in 2016 that focuses on developing quantum computing technology aimed at addressing complex real-world challenges. The company operates a quantum photonic platform designed to create accessible quantum computers for widespread use. By integrating advanced artificial intelligence with quantum silicon photonic chips, Xanadu develops a full-stack quantum computing solution that can seamlessly connect with existing hardware. This innovative approach enables clients to utilize quantum technology to effectively solve business problems, driving significant computational advancements over traditional methods. By combining academic research with industry expertise, Xanadu aims to make quantum computing widely available and beneficial for society.

Bingli

Series A in 2022
Bingli is a healthcare technology company that specializes in enhancing communication between patients and doctors through its innovative application. The application conducts smart pre-consultation interviews, allowing patients to accurately convey their symptoms to healthcare providers. This process not only prepares patients for their consultations but also enables physicians to save time, ultimately improving the quality of healthcare delivery. By streamlining the information-sharing process, Bingli aims to facilitate better patient outcomes and more efficient medical consultations.

Gradyent

Series A in 2022
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, that specializes in optimizing heating systems for district heating companies. Founded in 2019, Gradyent leverages Digital Twin technology, which involves creating a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows for real-time optimization of heating systems and facilitates simulations of future scenarios. As a result, clients can achieve significant reductions in heat loss, CO2 emissions, and fuel costs—averaging 20%, 10%, and 5-10%, respectively. Gradyent's platform not only enhances the efficiency of heating networks but also provides dynamic forecasting, real-time status updates, and automatic detection of network changes, allowing clients to securely access vital information from any location at any time.

StoryChief

Venture Round in 2022
StoryChief.io is a content marketing software designed for startups, SEO marketers, and editorial teams seeking to streamline their content creation and distribution processes. The platform enables users to publish stories across multiple channels, including WordPress, Medium, newsletters, and various social media platforms, all from a single interface. Its universal editor allows for the easy creation of visually appealing articles tailored for different publishing formats. Additionally, StoryChief offers features such as SEO suggestions, performance tracking, and lead capture integration with CRM systems, helping users measure their impact and return on investment effectively. By centralizing content management, StoryChief enhances the reach and efficiency of content marketing efforts.

Finquest

Seed Round in 2022
Finquest is a leading deal origination provider that specializes in delivering personalized connections for clients seeking mergers and acquisitions (M&A) and direct investment opportunities across Europe, North America, and the Asia-Pacific region. Utilizing a unique database and advanced machine learning techniques, Finquest offers targeted and curated introductions, facilitating a more efficient deal-making process while ensuring complete confidentiality. The company's platform focuses on the middle market, connecting institutional investors with potential investment opportunities and enabling corporate buyers to identify relevant acquirers. Headquartered in Singapore, Finquest operates offices in key financial centers including New York, Dallas, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong, broadening market access for its clients.

VoxelSensors

Seed Round in 2022
VoxelSensors specializes in advanced sensing technology that enhances spatial and empathic interfaces for mobile, extended reality (XR), and industrial applications. The company's proprietary Single Photon Active Event Sensor (SPAES) technology employs Single-Photon Avalanche Diodes (SPADs) to provide low-power, low-latency solutions for spatial awareness, gaze tracking, and intuitive user interactions. This innovative system architecture is tailored to meet the needs of manufacturers in the consumer electronics sector, enabling a new category of efficient three-dimensional perception systems. VoxelSensors' technology not only supports the growth of mobile and XR markets but also addresses the increasing demand for immersive and autonomous experiences across various industries. By leveraging this groundbreaking technology, VoxelSensors aims to transform consumer electronics, smartphones, wearables, and industrial applications, ultimately blurring the lines between the physical and digital worlds.

Zozio

Seed Round in 2022
Zozio is a logistics platform designed to enhance operational efficiency in factories by collecting, visualizing, and analyzing real-time field data both inside and outside the industrial environment. By utilizing AI algorithms, Zozio provides a digital companion for industrial operators, streamlining processes and alleviating the burden of manual, repetitive tasks for technical staff. The platform aims to transform traditional manufacturing practices into a Factory 4.0 model, ultimately improving working conditions for operators and reducing resource waste. This optimization enables manufacturers to enhance their supply chain efficiency and competitiveness on a global scale.

Econic Technologies

Series D in 2022
Econic Technologies Ltd. is a UK-based chemical technology company that specializes in developing innovative processes for producing polymers and polyurethanes using carbon dioxide and epoxides. Founded in 2011 and located in Macclesfield, the company focuses on transforming waste CO2 into valuable materials through advanced catalyst chemistry. Its product offerings include polycarbonates and polycarbonate polyols, which find applications in various sectors such as mattresses, home insulation, footwear, packaging, and construction. The company’s technology not only reduces dependence on fossil fuels but also aims to provide environmental benefits by mitigating greenhouse gas emissions. With a team of skilled scientists and engineers operating from a state-of-the-art facility at Alderley Park, Econic Technologies is committed to advancing sustainable practices in the plastics industry while fostering economic growth.

DMC Biotechnologies

Series B in 2021
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in developing bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on producing specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. Utilizing its Dynamic Metabolic Control technology, DMC Biotechnologies aims to enhance the efficiency and sustainability of production processes, reducing both energy consumption and resource use. This innovative approach allows for quicker development timelines and lower costs, supporting a transition towards a more sustainable economy.

Qpinch

Series B in 2021
Qpinch is a company that specializes in transforming industrial waste heat into carbon-neutral steam, which can be used to generate electricity and useful process heat. By utilizing their innovative chemical heat transformer, Qpinch helps businesses reduce their energy costs while minimizing their environmental impact. The company's technology is designed to integrate with existing industrial assets, allowing clients to achieve immediate savings on their energy bills. This focus on sustainability and efficiency positions Qpinch as a valuable partner for industries that rely on process heat.

Black Bear Carbon

Venture Round in 2021
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

EclecticIQ

Series C in 2020
EclecticIQ is a company specializing in threat intelligence and cybersecurity solutions. It develops advanced technology for threat hunting and response, aimed at enhancing organizations' defenses against cyber adversaries. The company's platform integrates and interprets intelligence data sourced from open sources, commercial suppliers, and industry partnerships. This enables enterprises to bolster their detection, prevention, and response capabilities by embedding actionable intelligence into their cybersecurity infrastructures. Through its offerings, EclecticIQ strives to empower organizations to effectively combat evolving cyber threats.

Sensolus

Venture Round in 2020
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

Innovium

Series F in 2020
Innovium, Inc. specializes in developing and deploying advanced switching silicon solutions for cloud, enterprise, and edge data centers. Founded in 2014 and headquartered in San Jose, California, with an additional location in Bengaluru, India, the company offers products such as TERALYNX 7 for large-scale public and private cloud applications and TERALYNX 5 for top-of-rack, enterprise, edge, and 5G data centers. Innovium also provides a cloud-based, open-source network operating system, along with standard APIs and a software development kit. The company's technology focuses on delivering scalable Ethernet switch solutions that enhance performance, programmability, and low latency, helping data centers address complex challenges effectively. Innovium is backed by several prominent venture capital firms.

Gradyent

Seed Round in 2020
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, that specializes in optimizing heating systems for district heating companies. Founded in 2019, Gradyent leverages Digital Twin technology, which involves creating a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows for real-time optimization of heating systems and facilitates simulations of future scenarios. As a result, clients can achieve significant reductions in heat loss, CO2 emissions, and fuel costs—averaging 20%, 10%, and 5-10%, respectively. Gradyent's platform not only enhances the efficiency of heating networks but also provides dynamic forecasting, real-time status updates, and automatic detection of network changes, allowing clients to securely access vital information from any location at any time.

ViroVet

Series B in 2020
ViroVet is an innovative company focused on developing groundbreaking technologies to combat viral diseases in livestock, particularly through antiviral drugs targeting respiratory disease complexes and novel vaccines for swine. The livestock industry, valued at over 100 billion euros, faces significant financial losses due to viral diseases, which threaten global animal protein supplies. ViroVet aims to supply livestock producers, national governments, and international organizations with comprehensive solutions that can be used independently or alongside existing vaccines and biosecurity measures. With the growing world population and increased demand for protein, the risk of viral disease spread in densely populated livestock environments is rising. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to reduce antibiotic use and transform the industry. Through its innovative approach, ViroVet addresses urgent challenges posed by endemic and epizootic viral diseases, ultimately aiming to enhance the resilience of the livestock sector.

VOID Technologies

Venture Round in 2020
VOID Technologies Limited is a materials science company based in London, United Kingdom, with a manufacturing facility in Neenah, Wisconsin. Established in 2014 as a subsidiary of Kimberly-Clark Corporation, the company specializes in producing VO+ additive masterbatches. These masterbatches are designed for film manufacturers and are utilized in a variety of applications, including labels, food packaging, bags, snacks, tapes, and strapping. The innovative VO+ technology incorporates plastic reduction techniques by engineering a nano-voided structure into both commodity and biopolymers, resulting in lighter, more sustainable products. This technology enables packaging manufacturers and consumer goods companies to create films suitable for diverse sectors such as packaging, industrial, agricultural, and medical applications.

Prolupin

Venture Round in 2020
Prolupin GmbH, founded in 2010 and based in Grimmen, Germany, specializes in the development and production of vegetable-based food ingredients derived from lupine seeds. As a spin-off from the Fraunhofer Institute for Process Engineering and Packaging, Prolupin leverages advanced expertise in lupine fractionation and food technology to create a range of products, including lupine protein isolate, ice cream, and various herbal food ingredients. These offerings cater to diverse sectors within the food industry, such as bakery, meat, pasta, and health foods, providing consumers with cholesterol-free, lactose-free, vegan, and gluten-free options. Prolupin's innovative approach is supported by multiple patents from the Fraunhofer Institute, solidifying its competitive position in the vegetable protein market.

DMC Biotechnologies

Series A in 2019
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in developing bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on producing specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. Utilizing its Dynamic Metabolic Control technology, DMC Biotechnologies aims to enhance the efficiency and sustainability of production processes, reducing both energy consumption and resource use. This innovative approach allows for quicker development timelines and lower costs, supporting a transition towards a more sustainable economy.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Arkite NV

Venture Round in 2019
Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

icometrix

Series A in 2019
icometrix is a company that specializes in the analysis of brain MRI scans to enhance personalized care for patients with neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix is headquartered in Leuven, Belgium, with an additional office in Boston, USA. The company has developed MSmetrix, a tool that identifies brain lesions, measures lesion volume, and assesses whole brain and grey matter volume and atrophy. MSmetrix has received market approval in the EU and several other countries, with FDA clearance pending. icometrix is recognized as a leader in MRI biomarkers for routine clinical practice and is certified in quality management and information security. Additionally, the company provides image analysis services for clinical trials and research studies, utilizing its software-as-a-service model to process large volumes of brain imaging data. This approach aids in advancing research on various neurological conditions, including traumatic brain injury, epilepsy, Alzheimer’s disease, and stroke, by using imaging biomarker outcomes as key endpoints in drug development.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Miaa Guard

Venture Round in 2019
Miaa Guard CVBA, based in Leuven, Belgium, develops a cloud-based platform that provides access control solutions for digital businesses. The platform utilizes microservice APIs to manage access rights and policies tailored to both consumers and professionals within an enterprise context. It enables organizations to govern security and access, integrate data architecture, and customize configurations. Founded in 2009 and originally known as VintiQ, the company rebranded to Miaa Guard CVBA in 2014. Its services facilitate the monetization of digital assets while ensuring proper authorization among users.

Black Bear Carbon

Venture Round in 2018
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

c-LEcta

Venture Round in 2018
c-LEcta GmbH, established in 2004 and headquartered in Leipzig, Germany, is a biotechnology company specializing in enzyme engineering and bioprocess development for regulated markets such as food and pharmaceuticals. The company develops, manufactures, and commercializes customized enzyme variants, either independently or through collaborative partnerships with industry. c-LEcta's product portfolio includes DENARASE, a genetically engineered endonuclease for nucleic acid removal and viscosity reduction, and CalB Immo Plus, a hydrophobic immobilized CalB preparation. The company's mission is to provide tailored enzymes and microbial strains for industrial applications, enabling clients to make new discoveries and enhance market penetration.

Nexstim

Post in 2018
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

LindaCare

Series B in 2018
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

DMC Biotechnologies

Seed Round in 2018
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in developing bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on producing specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. Utilizing its Dynamic Metabolic Control technology, DMC Biotechnologies aims to enhance the efficiency and sustainability of production processes, reducing both energy consumption and resource use. This innovative approach allows for quicker development timelines and lower costs, supporting a transition towards a more sustainable economy.

Ngdata

Series C in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Arkite NV

Venture Round in 2017
Arkite NV, founded in 2015 and based in Genk, Belgium, specializes in manufacturing automation products designed to enhance operational efficiency in manufacturing environments. Their flagship product, the Human Interface Mate (HIM), aids operators by providing real-time warnings for incorrect operations and guiding them towards standardized work processes. The company emphasizes the importance of a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to their product offerings, Arkite provides professional services, including process innovation consultancy, integration services, training, and support during the startup phase. They also assist clients with time studies for technology innovation, knowledge management to improve quality systems, and organizational innovations aimed at reducing throughput times.

Sensolus

Seed Round in 2017
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, providing comprehensive tracking solutions directly from the cloud. Established in 2013 and based in Ghent, Belgium, the company offers a range of low-power, context-aware sensing technologies, including its STICKNTRACK product line. Sensolus combines hardware GPS trackers with a fully integrated cloud application, enabling users to manage and monitor their assets with ease. The company serves various industries, including manufacturing, waste management, cargo transport, logistics, and automotive, focusing on delivering real-time information and maintenance-free asset tracking solutions.

ViroVet

Series A in 2017
ViroVet is an innovative company focused on developing groundbreaking technologies to combat viral diseases in livestock, particularly through antiviral drugs targeting respiratory disease complexes and novel vaccines for swine. The livestock industry, valued at over 100 billion euros, faces significant financial losses due to viral diseases, which threaten global animal protein supplies. ViroVet aims to supply livestock producers, national governments, and international organizations with comprehensive solutions that can be used independently or alongside existing vaccines and biosecurity measures. With the growing world population and increased demand for protein, the risk of viral disease spread in densely populated livestock environments is rising. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to reduce antibiotic use and transform the industry. Through its innovative approach, ViroVet addresses urgent challenges posed by endemic and epizootic viral diseases, ultimately aiming to enhance the resilience of the livestock sector.

FEops

Series B in 2017
FEops is a pioneer in physics-based simulations specifically tailored for minimally invasive cardiovascular devices and procedures. The company develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By utilizing artificial intelligence to conduct anatomical analyses, FEops provides data-driven insights that improve transcatheter valve procedures through personalized computer simulations. This approach offers medical device companies and healthcare professionals unique insights that streamline research and development processes, enhance procedural efficiency, and ultimately improve clinical outcomes and patient safety. Additionally, FEops supports medical specialists and physicians with patient-specific information, facilitating more effective treatments.

Ngdata

Series B in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Indigo Diabetes

Series A in 2016
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

Noona Healthcare

Seed Round in 2016
Noona Healthcare Oy is a Finnish company that specializes in a web-based mobile platform designed for monitoring the wellbeing of breast cancer patients. Founded in 2014 and based in Helsinki, Noona allows patients to report symptoms related to their treatment directly to their healthcare providers through mobile devices, tablets, and computers. This real-time communication enhances the patient-clinic relationship, enabling clinical staff to promptly address severe symptoms and improve overall care quality. The platform also supports researchers in developing new cancer therapies by integrating digital data with patient diagnosis, treatment, and genetic information. As a result, Noona Healthcare contributes to better patient outcomes and optimizes resource allocation in oncology care. The company operates as a subsidiary of Varian Medical Systems, Inc.

FRX Innovations

Series D in 2016
FRX Innovations is an industrial company based in Chelmsford, MA, that specializes in the manufacture of environmentally sustainable flame retardant solutions for various markets, including electronics, automotive, electric vehicles, and medical devices. The company produces a range of products under the brand name Nofia, which includes Nofia polyphosphonates, Nofia homopolymers, and Nofia reactive oligomers. These materials are characterized by their non-halogen, transparent, and high melt-flow properties, making them ideal for applications in textiles, electrical components, mass transit, and building construction. FRX Innovations employs sustainable green chemistry principles in its production processes, ensuring that its methods are solvent-free, generate no waste byproducts, and exhibit high atom efficiency. The company is currently in the growth phase, focusing on the commercialization of its innovative fire-resistant plastics.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company established in 2003 in Liège, Belgium, with a presence in Sparta, New Jersey, and a sales office in the United Kingdom. The company specializes in developing and commercializing advanced instruments and reagent systems for life science research and molecular diagnostics. Diagenode offers a technology platform that includes Bioruptor shearing and IP-Star automation instruments, along with reagent kits and quality antibodies. These products are designed to enhance workflows in epigenetics research, biological sample preparation, and diagnostic assays, serving a diverse clientele that includes prominent epigenetics researchers, academic institutions, genome centers, core laboratories, and pharmaceutical and biotechnology companies.

iSTAR Medical

Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

BlueBee

Series A in 2016
Bluebee is a prominent provider of high-performance genomics solutions that facilitate significant reductions in both costs and time-to-diagnosis for research and clinical laboratories. The company offers a cloud-based accelerated genomics platform designed for the fast and efficient processing of large volumes of genomic data. In light of transformative advancements in next-generation DNA sequencing technology, Bluebee addresses the challenges of handling increasing data volumes, the need for rapid data processing, and the demand for flexibility and reliability across diverse applications. By combining expertise in the field of genomics with high-performance computing and clinical-grade security, Bluebee's platform empowers healthcare institutions to explore new diagnostic methods and therapeutic options.

LindaCare

Series A in 2015
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

Ngdata

Series B in 2015
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Sequana Medical

Series C in 2015
Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

Ogeda

Series B in 2015
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that focuses on inventing and developing small molecule drugs that target G-Protein Coupled Receptors (GPCRs). The company's lead product, fezolinetant, is currently in Phase II clinical development for treating women's health disorders. In addition to fezolinetant, Ogeda is developing other small molecules aimed at addressing various therapeutic areas, including inflammatory and autoimmune diseases. Founded in 1994 and formerly known as Euroscreen, Ogeda operates additional facilities in Brussels, Belgium, and Paris, France. The company is a subsidiary of Astellas Pharma Inc. and is supported by prominent investors in the biotechnology sector.

NovoPolymers

Venture Round in 2015
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

FEops

Series A in 2015
FEops is a pioneer in physics-based simulations specifically tailored for minimally invasive cardiovascular devices and procedures. The company develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By utilizing artificial intelligence to conduct anatomical analyses, FEops provides data-driven insights that improve transcatheter valve procedures through personalized computer simulations. This approach offers medical device companies and healthcare professionals unique insights that streamline research and development processes, enhance procedural efficiency, and ultimately improve clinical outcomes and patient safety. Additionally, FEops supports medical specialists and physicians with patient-specific information, facilitating more effective treatments.

Green Biologics

Series C in 2015
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

SpaceX

Series G in 2015
SpaceX, officially known as Space Exploration Technologies, is a space transportation company founded in 2002 by Elon Musk and headquartered in Hawthorne, California. The company specializes in the design, manufacture, and launch of advanced rockets and spacecraft, including notable vehicles such as Falcon Heavy, Dragon, and Starship. SpaceX develops a range of technologies including crew and cargo capsules, rocket engines, and avionics, alongside guidance and control software. A key focus of SpaceX is the creation of partially reusable launch vehicles, such as Falcon 1 and Falcon 9, which aim to reduce the costs associated with space travel. By enabling the transport of cargo, humans, and payloads into space, SpaceX seeks to advance the capabilities and affordability of space exploration and travel.

Avantium

Series G in 2014
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.

Sequana Medical

Series C in 2014
Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

FRX Innovations

Series C in 2014
FRX Innovations is an industrial company based in Chelmsford, MA, that specializes in the manufacture of environmentally sustainable flame retardant solutions for various markets, including electronics, automotive, electric vehicles, and medical devices. The company produces a range of products under the brand name Nofia, which includes Nofia polyphosphonates, Nofia homopolymers, and Nofia reactive oligomers. These materials are characterized by their non-halogen, transparent, and high melt-flow properties, making them ideal for applications in textiles, electrical components, mass transit, and building construction. FRX Innovations employs sustainable green chemistry principles in its production processes, ensuring that its methods are solvent-free, generate no waste byproducts, and exhibit high atom efficiency. The company is currently in the growth phase, focusing on the commercialization of its innovative fire-resistant plastics.

Arcus Financial Intelligence

Seed Round in 2014
Arcus Financial Intelligence, Inc. is a New York-based company that develops and operates an application program interface (API) platform designed for banks and financial institutions. The platform focuses on managing consumer bills and financial data, offering real-time bill management and payment services. Users can gain insights into their family finances, including details about outstanding bills, amounts owed, and due dates. Additionally, Arcus provides a multi-rail payment platform that facilitates various payment methods, making payments more accessible for consumers. Founded in 2012 and originally known as Regalii Inc., the company rebranded to Arcus Financial Intelligence, Inc. in June 2018.

Green Biologics

Series B in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

iSTAR Medical

Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in developing radiofrequency (RF) ablation devices. One of its key products, the EncageTM, is a percutaneous RF device designed to precisely ablate soft tissues, minimizing collateral damage during procedures. This technology is particularly significant in the treatment of prostate cancer, a prevalent condition with approximately 240,000 new cases diagnosed annually in the United States. Traditional treatments often lead to severe side effects, such as erectile dysfunction and urinary incontinence, highlighting the importance of Trod Medical's advancements. The company's devices enable healthcare providers to perform endoscopic surgeries with predictable ablation volumes and reduced tissue damage, aiming to improve patient outcomes in a critical area of medical care.

Ngdata

Series A in 2013
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Green Biologics

Venture Round in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Mainstay Medical

Series B in 2012
Mainstay Medical is a global medical device company based in Dublin, Ireland, with operations in the United States and Australia. The company focuses on developing innovative therapies for individuals suffering from chronic low back pain, a condition that affects a significant portion of the population. Mainstay Medical has created a FDA-approved restorative treatment aimed at addressing mechanical chronic low back pain. This treatment is designed to help restore muscle control and enhance functionality in the lumbar spine, ultimately improving the quality of life for patients. By collaborating with scientists and clinical experts, Mainstay Medical strives to provide effective solutions for those in need of relief from debilitating pain.

Metallkraft AS

Acquisition in 2012
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Green Biologics

Venture Round in 2012
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Trinean

Venture Round in 2012
Trinean is a Belgium-based technology provider that specializes in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers tailored for biomolecule quantification. Its products, the DropSense™16 and DropSense™96, can analyze up to 16 and 96 samples, respectively, utilizing microfluidic chips for standardized sample analysis. These instruments are designed to enhance data interpretation and facilitate laboratory automation, making them valuable tools for biologics researchers. Trinean combines its advanced analytical hardware with a comprehensive software toolbox to optimize the performance of its spectrometers.

NovoPolymers

Venture Round in 2012
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Liquidity Nanotech Corporation

Series A in 2011
Liquidity manufactures breakthrough water purification cartridges, based on revolutionary membrane nanoscience, to solve the world's potable water needs. Pour any non-salt water through their cartridge and drink it safely. It's that simple. No chemicals, no power nor pressure. Their product will save millions of lives currently lost to preventable waterborne diseases.

EpiGan

Venture Round in 2011
EpiGaN is a Leuven, Belgium-based company that specializes in the development of Gallium Nitride on Silicon (GaN) wafers. The company produces III-nitride epitaxial materials, primarily gallium nitride, which are known for their high power efficiency and reduced power losses. These materials are suited for a range of commercial applications, including AC drives, uninterruptible power supply (UPS) inverters, and hybrid and electric vehicles. EpiGaN's innovative technology aims to enhance performance and efficiency in various electronic systems.

FRX Innovations

Series B in 2011
FRX Innovations is an industrial company based in Chelmsford, MA, that specializes in the manufacture of environmentally sustainable flame retardant solutions for various markets, including electronics, automotive, electric vehicles, and medical devices. The company produces a range of products under the brand name Nofia, which includes Nofia polyphosphonates, Nofia homopolymers, and Nofia reactive oligomers. These materials are characterized by their non-halogen, transparent, and high melt-flow properties, making them ideal for applications in textiles, electrical components, mass transit, and building construction. FRX Innovations employs sustainable green chemistry principles in its production processes, ensuring that its methods are solvent-free, generate no waste byproducts, and exhibit high atom efficiency. The company is currently in the growth phase, focusing on the commercialization of its innovative fire-resistant plastics.

Nexstim

Venture Round in 2011
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, it focuses on developing and marketing navigated transcranial magnetic stimulation (nTMS) systems, utilizing its proprietary SmartFocus technology with 3D navigation for precise targeting of brain regions. The company offers the NBT system for treating major depressive disorder and chronic neuropathic pain, as well as the NBS system for pre-surgical mapping of speech and motor cortices. Nexstim primarily serves universities and teaching hospitals, with a significant portion of its revenue generated in North America and its products marketed across Europe and internationally.

Sequana Medical

Series B in 2011
Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

NovoPolymers

Series B in 2011
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Ensartech

Venture Round in 2011
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

Ducatt

Venture Round in 2010
Ducatt NV is a clean-tech start-up located in Belgium that specializes in the manufacturing of solar glasses. These ultra-clear patterned glasses are designed to enhance the efficiency of solar systems, offering various thicknesses to meet different client needs. Ducatt's products aim to make solar technology more accessible and affordable, contributing to the growing demand for sustainable energy solutions.

Green Biologics

Series B in 2010
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Anteryon International

Venture Round in 2010
Anteryon, based in Eindhoven, the Netherlands, is a manufacturer specializing in optical precision elements and miniature optical modules. Originally a business unit of Philips, it became an independent entity in 2006. The company focuses on providing standard and customized optical components, utilizing patented replication and opto-mechanical assembly technologies, alongside expertise in coatings, lithography, and precision glass. Anteryon serves diverse markets, including industrial, imaging and display, and data and telecom, delivering solutions that encompass lenses, laser modules, fiber collimators, and integrated lens stacks. Its products are integral to various applications, such as automotive safety systems, optical data storage, and multiview displays. Notably, Anteryon's innovations include WaferOptics® technology, facilitating advanced stacking techniques at the wafer level. The company is well-positioned for growth in the mobile phone camera module sector, catering to an expanding global demand for camera-enabled devices.

FRX Innovations

Series A in 2009
FRX Innovations is an industrial company based in Chelmsford, MA, that specializes in the manufacture of environmentally sustainable flame retardant solutions for various markets, including electronics, automotive, electric vehicles, and medical devices. The company produces a range of products under the brand name Nofia, which includes Nofia polyphosphonates, Nofia homopolymers, and Nofia reactive oligomers. These materials are characterized by their non-halogen, transparent, and high melt-flow properties, making them ideal for applications in textiles, electrical components, mass transit, and building construction. FRX Innovations employs sustainable green chemistry principles in its production processes, ensuring that its methods are solvent-free, generate no waste byproducts, and exhibit high atom efficiency. The company is currently in the growth phase, focusing on the commercialization of its innovative fire-resistant plastics.

NovoPolymers

Series A in 2009
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Neosens

Series B in 2009
Neosens SA specializes in the design and development of sensor solutions aimed at monitoring and controlling the quality of water and industrial liquids. The company offers advanced sensors that detect dissolved oxygen and systems for continuous fouling monitoring. Its technologies are applied across various sectors, including cooling systems, heat exchangers, potable and ultra-pure water management, as well as in industries such as food and beverage, pharmaceuticals, pulp and paper, and oil and gas. Founded in 2001 and headquartered in Labege, France, Neosens is committed to providing innovative solutions that enhance the efficiency and safety of liquid management in diverse environmental applications.

Metallkraft AS

Series A in 2008
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Avantium

Venture Round in 2008
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.

Fluxome

Series B in 2008
Fluxome is a global supplier of natural ingredients aimed at enhancing human health and wellness. The company specializes in producing nutraceutical ingredients, notably pure resveratrol, derived from renewable sources through innovative technology. Fluxome's commitment to developing safe and natural health products distinguishes it in the market, as it seeks to provide effective solutions that can positively impact its customers' well-being.

Ensartech

Venture Round in 2008
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

CoreOptics

Venture Round in 2008
CoreOptics specializes in providing advanced solutions for high-speed optical networking applications within the telecommunications and information technology sectors. The company is recognized for its 10G and 40G Distortion Tolerant Transponder Modules and integrated circuit solutions, which are essential for Metro, Regional, and Long Haul optical and data networks. CoreOptics advocates for open optical communication systems that can efficiently transmit data across various rates and fiber types. Its innovative maximum likelihood sequence estimation (MLSE)-based equalization technology is notable for enabling Tier 1 systems vendors and carriers to enhance network performance without overhauling existing fiber infrastructure. By eliminating the need for Optical Compensators and Second Stage Amplifiers, CoreOptics' products can significantly lower first-in deployment costs for customers, achieving reductions of up to 30%.

iNEWiT

Venture Round in 2008
iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. The company specializes in identifying, designing, and creating applications and devices for the mobile market. It develops mobile video communication applications and offers a range of wireless communication technologies, including GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. iNEWiT's products utilize patent-pending technology to transmit data, video, and sound across various wireless and wired environments and platforms. Additionally, the company provides plug-and-play products tailored for the business-to-consumer markets.

Neosens

Venture Round in 2008
Neosens SA specializes in the design and development of sensor solutions aimed at monitoring and controlling the quality of water and industrial liquids. The company offers advanced sensors that detect dissolved oxygen and systems for continuous fouling monitoring. Its technologies are applied across various sectors, including cooling systems, heat exchangers, potable and ultra-pure water management, as well as in industries such as food and beverage, pharmaceuticals, pulp and paper, and oil and gas. Founded in 2001 and headquartered in Labege, France, Neosens is committed to providing innovative solutions that enhance the efficiency and safety of liquid management in diverse environmental applications.

Certess

Venture Round in 2007
Certess is an electronic design automation (EDA) company that specializes in functional qualification products aimed at businesses developing and integrating complex design blocks or intellectual property (IP). The company's software addresses the challenges faced by advanced functional verification teams, who often struggle to achieve true verification quality despite using various techniques. Certess provides tools that enable design and verification engineers to objectively evaluate and enhance the completeness of their verification environments, which helps reduce functional logic errors—key contributors to chip respins. By streamlining the integration process of System-on-Chip (SoC) designs, Certess ensures higher quality outcomes. Founded in 2005 and based in Campbell, California, Certess was acquired by SpringSoft, LLC in March 2009.

Mendel Biotechnology

Series D in 2007
Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

MAPPER Lithography

Series B in 2007
MAPPER Lithography B.V. specializes in developing maskless lithography infrastructure for the semiconductor industry. Founded in 2000 and headquartered in Delft, the Netherlands, the company designs and manufactures tools that utilize multiple electron-beam technology for semiconductor production. This innovative approach enables the fabrication of chips without the need for traditional masks, streamlining the manufacturing process. MAPPER Lithography also operates a manufacturing facility in Moscow, Russia, further supporting its capabilities in the semiconductor sector.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in delivering innovative solutions for electronic payments processing. The company's Open Payment Framework (OPF) provides financial institutions with the ability to enhance the efficiency of their internal payment systems while offering clients improved services characterized by speed and comprehensive payment information. Clear2Pay's OPF operates within a Service-Oriented Architecture, enabling banks to process payments through a centralized engine that utilizes a library of reusable business services across various payment types. This approach allows financial institutions to integrate new service models with existing infrastructures, ensuring the protection of previous investments while transitioning to a more modern and efficient payment environment. Additionally, Clear2Pay provides a Software Development Kit and a Bank Payment Hub, which offer tools for implementing payment solutions and managing customer interactions, order execution, and dispute processing.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Welcome Real Time

Venture Round in 2005
Welcome Real Time S.A. is a company that specializes in electronic payment software and services, primarily for financial institutions, payment networks, and retailers. Established in 1996 and headquartered in Aix-en-Provence, France, it offers a variety of solutions including credit and debit card acceptance, and integrated value-added services. Key products include XLS Server, which enhances EMV capabilities for payment processing systems; XLS POS, a toolkit for developing payment applications; and XLS Card, which supports card personalization and issuance. Additionally, Welcome Real Time provides CardCare for cardholder services and MerchantCare for merchant activity reporting. With research and development facilities in multiple global locations, the company focuses on creating point-of-sale customer loyalty programs and smart payment device software, along with offering maintenance and marketing consulting services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.